Nabil A Elshourbagy
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$6.2MFederal grants as PI7 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
7 awards · $6.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jun 13, 2025 | NIH | SBIR Phase II Executing the IND-Enabling Studies for Oral PCSK9/LDLR antagonist | $1.2M | SHIFA BIOMEDICAL CORPORATION |
| Aug 8, 2024 | NIH | SBIR Phase II Executing the IND-Enabling Studies for Oral PCSK9/LDLR antagonist | $1.3M | SHIFA BIOMEDICAL CORPORATION |
| Apr 20, 2021 | NIH | SBIR Phase II Oral PCSK9/LDLR antagonist direction to the clinic | $945K | SHIFA BIOMEDICAL CORPORATION |
| Apr 24, 2020 | NIH | SBIR Phase II Oral PCSK9/LDLR antagonist direction to the clinic | $944K | SHIFA BIOMEDICAL CORPORATION |
| May 3, 2018 | NIH | SBIR Phase II Development of Oral Small Molecule PCSK9 Antagonist | $667K | SHIFA BIOMEDICAL CORPORATION |
| Sep 8, 2017 | NIH | SBIR Phase II Development of Oral Small Molecule PCSK9 Antagonist | $682K | SHIFA BIOMEDICAL CORPORATION |
| Apr 29, 2015 | NIH | SBIR Phase II Novel Modulators of LDL Metabolism | $500K | SHIFA BIOMEDICAL CORPORATION |
Peer ranks
Federal funding#176
Awards as PI#250
Patents#273
Companies
- SHIFA BIOMEDICAL CORPORATIONLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.